Fair Value Measurement and Disclosures - Schedule of the Valuation of the Company's Investments in the Fair Value Hierarchy Levels (Parenthetical) (Detail) - USD ($) $ in Thousands |
Jun. 30, 2025 |
Dec. 31, 2024 |
||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||||||||||||||||||
Fair Value | $ 940,619 | $ 631,905 | ||||||||||||||||
Investments Measured at NAV [Member] | ||||||||||||||||||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||||||||||||||||||
Fair Value | $ 377,464 | [1],[2],[3] | $ 201,670 | [4],[5],[6],[7] | ||||||||||||||
Investment, Type [Extensible Enumeration] | Investment in Preferred Units of Liability Company [Member] | Investment in Preferred Units of Liability Company [Member] | ||||||||||||||||
Unfunded commitments | $ 259,498 | $ 30,240 | ||||||||||||||||
Investments Measured at NAV [Member] | Investment in Preferred Units of Liability Company [Member] | ||||||||||||||||||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||||||||||||||||||
Fair Value | 269,154 | 114,695 | ||||||||||||||||
Series I [Member] | ||||||||||||||||||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||||||||||||||||||
Fair Value | 279,314 | 166,652 | ||||||||||||||||
Series I [Member] | Investments Measured at NAV [Member] | ||||||||||||||||||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||||||||||||||||||
Fair Value | $ 112,087 | [1],[2],[3] | $ 53,186 | [4],[5],[6],[7] | ||||||||||||||
Investment, Type [Extensible Enumeration] | Investment in Preferred Units of Liability Company [Member] | Investment in Preferred Units of Liability Company [Member] | ||||||||||||||||
Unfunded commitments | $ 77,081 | $ 7,975 | ||||||||||||||||
Series I [Member] | Investments Measured at NAV [Member] | Investment in Preferred Units of Liability Company [Member] | ||||||||||||||||||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||||||||||||||||||
Fair Value | 79,941 | 30,248 | ||||||||||||||||
Series II [Member] | ||||||||||||||||||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||||||||||||||||||
Fair Value | 661,305 | 465,253 | ||||||||||||||||
Series II [Member] | Investments Measured at NAV [Member] | ||||||||||||||||||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||||||||||||||||||
Fair Value | $ 265,377 | [1],[2],[3] | $ 148,484 | [4],[5],[6],[7] | ||||||||||||||
Investment, Type [Extensible Enumeration] | Investment in Preferred Units of Liability Company [Member] | Investment in Preferred Units of Liability Company [Member] | ||||||||||||||||
Unfunded commitments | $ 182,417 | $ 22,265 | ||||||||||||||||
Series II [Member] | Investments Measured at NAV [Member] | Investment in Preferred Units of Liability Company [Member] | ||||||||||||||||||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||||||||||||||||||
Fair Value | $ 189,213 | $ 84,447 | ||||||||||||||||
|